KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Fulgent Genetics (FLGT) Research & Development (2016 - 2026)

Fulgent Genetics' Research & Development history spans 12 years, with the latest figure at $14.2 million for Q1 2026.

  • On a quarterly basis, Research & Development rose 14.37% to $14.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was $55.7 million, a 11.87% increase, with the full-year FY2025 number at $53.9 million, up 10.42% from a year prior.
  • Research & Development hit $14.2 million in Q1 2026 for Fulgent Genetics, roughly flat from $14.2 million in the prior quarter.
  • Over the last five years, Research & Development for FLGT hit a ceiling of $14.2 million in Q1 2026 and a floor of $6.0 million in Q1 2022.
  • Historically, Research & Development has averaged $11.0 million across 5 years, with a median of $11.8 million in 2024.
  • Biggest five-year swings in Research & Development: surged 63.33% in 2023 and later dropped 0.04% in 2025.
  • Tracing FLGT's Research & Development over 5 years: stood at $8.5 million in 2022, then skyrocketed by 40.46% to $12.0 million in 2023, then grew by 1.35% to $12.1 million in 2024, then grew by 16.98% to $14.2 million in 2025, then grew by 0.04% to $14.2 million in 2026.
  • Business Quant data shows Research & Development for FLGT at $14.2 million in Q1 2026, $14.2 million in Q4 2025, and $13.9 million in Q3 2025.